|
EP4103231A4
(en)
|
2020-02-14 |
2024-03-27 |
Geovax, Inc. |
VACCINES AND THEIR USES TO INDUCE AN IMMUNE RESPONSE AGAINST SARS-COV2
|
|
US20230184764A1
(en)
*
|
2020-04-06 |
2023-06-15 |
The Trustees Of Columbia University In The City Of New York |
Peptide sequences for detection and differentiation of antibody responses to sars-cov-2 and other human corona viruses
|
|
US12558415B2
(en)
*
|
2020-04-14 |
2026-02-24 |
The Regents Of The University Of California |
Broad-spectrum multi-antigen pan-coronavirus vaccine
|
|
IL297419B2
(en)
|
2020-04-22 |
2025-02-01 |
BioNTech SE |
Coronavirus vaccine
|
|
US20230241202A1
(en)
*
|
2020-05-29 |
2023-08-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Adenovirus-Based SARS-CoV-2 Vaccine
|
|
US20230263883A1
(en)
*
|
2020-07-08 |
2023-08-24 |
The Brigham And Women`S Hospital, Inc. |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Peptide Epitopes
|
|
WO2022025264A1
(ja)
*
|
2020-07-31 |
2022-02-03 |
東亞合成株式会社 |
ＳＡＲＳ－ＣｏＶ－２由来のアミノ酸配列およびその利用
|
|
US12247978B2
(en)
*
|
2020-08-05 |
2025-03-11 |
Arizona Board Of Regents On Behalf Of Northern Arizona University |
Compositions and methods for detection and treatment of coronavirus infection
|
|
TWI884296B
(zh)
*
|
2020-08-11 |
2025-05-21 |
美商碩騰服務公司 |
抗冠狀病毒疫苗
|
|
CN112029781B
(zh)
*
|
2020-08-14 |
2023-01-03 |
中山大学 |
一种新型冠状病毒SARS-CoV-2的安全型复制子系统及其应用
|
|
US12419948B2
(en)
*
|
2020-08-31 |
2025-09-23 |
The Broad Institute, Inc. |
Immunogenic compositions and use thereof
|
|
WO2022051223A1
(en)
*
|
2020-09-02 |
2022-03-10 |
The Feinstein Institutes For Medical Research |
Use of sars-cov-2 receptor binding motif (rbm)-reactive monoclonal antibodies to treat covid-19
|
|
JP2023550094A
(ja)
*
|
2020-11-12 |
2023-11-30 |
ティースキャン セラピューティクス インコーポレイテッド |
Ｓａｒｓ－ｃｏｖ－２免疫優性ペプチドの構築物及びその使用
|
|
JP7598538B2
(ja)
|
2021-01-29 |
2024-12-12 |
東亞合成株式会社 |
ＳＡＲＳ－ＣｏＶ－２由来のアミノ酸配列およびその利用
|
|
US20240192211A1
(en)
*
|
2021-02-24 |
2024-06-13 |
Biotome Pty Ltd |
Peptides and their use in diagnosis of sars-cov-2 infection
|
|
US20220356212A1
(en)
*
|
2021-03-26 |
2022-11-10 |
Nanogen Pharmaceutical Biotechnology JSC |
Modified spike protein and method of treatment
|
|
EP4070814A1
(en)
*
|
2021-04-07 |
2022-10-12 |
Lama France |
Sars-cov-2 polypeptides and uses thereof
|
|
DK4319803T3
(da)
|
2021-04-08 |
2025-12-15 |
Vaxthera Sas |
Coronavirusvaccine omfattende et mosaikprotein
|
|
WO2022221189A1
(en)
*
|
2021-04-12 |
2022-10-20 |
La Jolla Institute For Immunology |
Coronavirus t cell epitopes and uses thereof
|
|
WO2022268916A2
(en)
*
|
2021-06-23 |
2022-12-29 |
Ose Immunotherapeutics |
Pan-coronavirus peptide vaccine
|
|
WO2023044542A1
(en)
*
|
2021-09-24 |
2023-03-30 |
The University Of Adelaide |
Sars cov-2 vaccine
|
|
WO2023049983A1
(en)
*
|
2021-09-28 |
2023-04-06 |
Medicago Inc. |
Cpmv vlps displaying sars-cov-2 epitopes
|
|
CN113981140B
(zh)
*
|
2021-10-09 |
2024-02-27 |
广州达安基因股份有限公司 |
新型冠状病毒德尔塔突变株的检测方法及核酸检测试剂盒
|
|
EP4419136A1
(en)
*
|
2021-10-21 |
2024-08-28 |
BioNTech SE |
Coronavirus vaccine
|
|
WO2023067193A2
(en)
|
2021-10-22 |
2023-04-27 |
BioNTech SE |
Compositions for administration of different doses of rna
|
|
US20250295755A1
(en)
|
2021-10-22 |
2025-09-25 |
Sail Biomedicines, Inc. |
Mrna vaccine composition
|
|
WO2023096896A2
(en)
*
|
2021-11-23 |
2023-06-01 |
nference, inc. |
Detection of covid-19 associated cardiac injury and vaccine-associated myocarditis
|
|
CA3238764A1
(en)
|
2021-11-23 |
2023-06-01 |
Siddharth Patel |
A bacteria-derived lipid composition and use thereof
|
|
US12186387B2
(en)
|
2021-11-29 |
2025-01-07 |
BioNTech SE |
Coronavirus vaccine
|
|
EP4445906A1
(en)
*
|
2021-12-08 |
2024-10-16 |
Anda Biology Medicine Development (Shenzhen) Co., Ltd. |
Antigenic polypeptide and use thereof
|
|
EP4452239A1
(en)
|
2021-12-20 |
2024-10-30 |
Sail Biomedicines, Inc. |
Compositions comprising mrna and lipid reconstructed plant messenger packs
|
|
CN114686620B
(zh)
*
|
2022-01-21 |
2024-05-07 |
生物岛实验室 |
新型冠状病毒多种变异株核酸质谱检测的引物组合、试剂盒及检测方法
|
|
CN114729373B
(zh)
*
|
2022-01-27 |
2023-01-31 |
深圳市瑞吉生物科技有限公司 |
一种新型冠状病毒mRNA疫苗及其制备方法与应用
|
|
EP4469079A1
(en)
*
|
2022-01-28 |
2024-12-04 |
Pfizer Inc. |
Coronavirus antigen variants
|
|
WO2023147091A1
(en)
*
|
2022-01-28 |
2023-08-03 |
BioNTech SE |
Coronavirus vaccine
|
|
AU2023219116A1
(en)
*
|
2022-02-08 |
2024-08-15 |
Iowa State University Research Foundation, Inc. |
Mrna expression and delivery systems
|
|
GB202201768D0
(en)
*
|
2022-02-11 |
2022-03-30 |
Virax Biolabs Uk Ltd |
Peptides
|
|
EP4486375A1
(en)
*
|
2022-03-02 |
2025-01-08 |
ISR Immune System Regulation Holding AB (publ) |
Vaccine composition comprising an antigen and a tlr3 agonist
|
|
CN116768988A
(zh)
*
|
2022-03-09 |
2023-09-19 |
中生复诺健生物科技(上海)有限公司 |
编码新型冠状病毒S蛋白的mRNA疫苗
|
|
CN114907452B
(zh)
*
|
2022-04-08 |
2023-07-25 |
国科宁波生命与健康产业研究院 |
一种用于治疗SARS-CoV-2病毒感染的M蛋白多肽
|
|
CN114907454A
(zh)
*
|
2022-04-08 |
2022-08-16 |
国科宁波生命与健康产业研究院 |
一种用于治疗SARS-CoV-2病毒感染的N蛋白多肽
|
|
CN114907453B
(zh)
*
|
2022-04-08 |
2023-07-25 |
国科宁波生命与健康产业研究院 |
一种用于治疗SARS-CoV-2病毒感染的S蛋白多肽
|
|
WO2023213990A1
(en)
|
2022-05-05 |
2023-11-09 |
Etherna Immunotherapies Nv |
Multi-epitope construct
|
|
WO2024002985A1
(en)
|
2022-06-26 |
2024-01-04 |
BioNTech SE |
Coronavirus vaccine
|
|
LU103079B1
(en)
*
|
2023-02-28 |
2024-08-28 |
PMCR GmbH |
IMMUNIZATION AGAINST VIRAL INFECTIONS DISEASE(S)
|
|
EP4631527A1
(en)
*
|
2022-12-09 |
2025-10-15 |
Seoul National University R&DB Foundation |
Nanoparticle comprising peptide-based conjugate for delivering mrna into b cell and t cell and uses thereof
|
|
EP4631528A1
(en)
*
|
2022-12-09 |
2025-10-15 |
Nibec Co., Ltd. |
Nanoparticle comprising peptide-based conjugate for delivering oligonucleotide into target cell and pharmaceutical composition comprising same
|
|
JP2026501447A
(ja)
*
|
2022-12-16 |
2026-01-15 |
ジーニアス・バイオテクノロジー・インコーポレイテッド |
多重抗原性ｒｎａ ｓａｒｓ－ｃｏｖ－２ワクチン及び関連する方法
|
|
PL443854A1
(pl)
*
|
2023-02-22 |
2024-08-26 |
Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk |
Epitop pochodzący z białka N wirusa SARS-CoV-2, zawierający go antygen, ich zastosowania i sposób wykrywania choroby wywoływanej przez koronawirusa
|
|
EP4669348A1
(en)
|
2023-02-24 |
2025-12-31 |
BioNTech SE |
IMMUNOGENEOUS COMPOSITIONS
|
|
EP4676530A2
(en)
*
|
2023-03-06 |
2026-01-14 |
Vakston, Inc. |
Nucleocapsid antigen immunotherapy for covid-19 fusion proteins and methods of use
|
|
WO2024263826A1
(en)
*
|
2023-06-22 |
2024-12-26 |
Modernatx, Inc. |
Sars-cov-2 t cell vaccines
|
|
WO2025101631A2
(en)
*
|
2023-11-07 |
2025-05-15 |
BioNTech SE |
Compositions and methods for preparing vaccines
|
|
WO2025106754A1
(en)
|
2023-11-15 |
2025-05-22 |
BioNTech SE |
Coronavirus vaccine
|
|
FR3155424A1
(fr)
|
2023-11-15 |
2025-05-23 |
BioNTech SE |
Compositions immunogènes contre le sars-cov-2
|
|
CN118955657B
(zh)
*
|
2024-01-09 |
2025-03-04 |
中山大学 |
一种特异性表位多肽及其试剂盒和应用
|
|
WO2025164815A1
(ko)
*
|
2024-01-29 |
2025-08-07 |
주식회사 나이벡 |
안지오텐신전환효소 2(ace2)에 대한 결합능이 있는 신규한 펩타이드 및 이의 용도
|
|
CN119144611A
(zh)
*
|
2024-09-19 |
2024-12-17 |
宁夏农林科学院枸杞科学研究所 |
黑果枸杞LrCHS2基因及其编码蛋白在促进枸杞花青素生物合成中的应用
|
|
CN120081914A
(zh)
*
|
2025-01-03 |
2025-06-03 |
中国人民解放军军事科学院军事医学研究院 |
一种HLA-C限制性SARS-CoV-2淋巴细胞抗原表位肽及其应用
|